Cardiomyopathies Assessment and Management Quiz

Atrial cardiomyopathy is not classified as a type of cardiomyopathy.

Left ventricular hypertrophy is the hallmark feature of hypertrophic cardiomyopathy.

Echocardiography is commonly used for the diagnosis of cardiomyopathies.

Beta-blockers are typically used for symptomatic relief and management in dilated cardiomyopathy.

MYH7 is commonly associated with hypertrophic cardiomyopathy.

Amyloidosis is the primary cause of restrictive cardiomyopathy.

Normal coronary arteries on angiography are a characteristic feature of takotsubo cardiomyopathy.

Antiarrhythmic drugs are the primary treatment for arrhythmias associated with hypertrophic cardiomyopathy.

Fibrofatty replacement of myocardium is a characteristic feature of arrhythmogenic right ventricular cardiomyopathy (ARVC).

Septal myectomy is often considered in severe cases of hypertrophic obstructive cardiomyopathy (HOCM).

The main goal of pharmacological management in hypertrophic obstructive cardiomyopathy (HOCM) is to alleviate left ventricular hypertrophy.

Hypertrophic cardiomyopathy is often associated with a family history of sudden cardiac death.